It has been known for several years that progesterone has a protective effect on ovarian cancer, the mechanism attributed to a reversal of the transformed phenotype including reduction of cyclin-dependent kinase activity and increased Fas/FasL-induced apoptosis (Blumenthal et al, 2003; Syed and Ho, 2003). Here, FASLG is linked to ovarian carcinoma.